Padsevonil is one of 40 small molecule programs targeting Focal-onset seizure. It is currently in Phase 2.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
221 competitors in Epilepsy
Briviact
Epidiolex
Dayvigo
Depacon
Zonegran
Actemra
Deltavit
Narcan
Lamictal
Usual Treatment
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources